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Evidence for a function of death-receptor-related, death-domain-
containing proteins in anoikis
Steven M. Frisch
Normal epithelial cells undergo apoptosis if integrin-
mediated matrix contacts are lost, in a process termed
‘anoikis’. Anoikis prevents shed epithelial cells from
colonizing elsewhere, and is thus essential for
maintaining appropriate tissue organisation. Aberrant
oncogenes or tumor suppressor genes can cause
resistance to anoikis, thereby contributing substantially
to malignancy. Apoptosis is mediated by a well-ordered
signaling cascade, which involves activation of
intracellular proteases known as caspases. However,
the mechanism by which the caspase cascade is
initiated following cell–matrix detachment is unknown.
We have hypothesized that death receptor activation
might be involved in anoikis. To test this hypothesis, we
developed a transient assay for anoikis and used it to
assay the effects of proteins that block the function of
domains found within death receptors known as death
domains. In this assay, silencer of death domains
(SODD) and dominant-negative FAS-associated death
domain protein (FADD) efficiently inhibited anoikis in
Madin–Darby canine kidney (MDCK) cells. The
protective activity of SODD required its BAG domain,
which interacts with the heat shock proteins hsp70 and
hsc70, and inhibits the chaperone activity of the latter.
Both caspase 8, which physically associates with death
receptors, and cleavage of the caspase-8 substrate BID,
were activated by cell–matrix detachment. These
findings indicate a role for death receptors or proteins
with related death domains in triggering anoikis.
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Results and discussion
We have developed an efficient assay for the effects of
transiently transfected genes on anoikis. In this assay, the
gene to be tested is co-transfected into cells with a Myc-
epitope-tagged caspase-6 substrate, cytokeratin-18 (K18;
Figure 1a) [1,2]. Transfected cells are suspended for
various times to allow for activation of the caspase
cascade, lysed and analyzed by western blotting for the
presence of the 26 kDa amino-terminal fragment of K18
that results from cleavage by Caspase 6 and the 48 kDa
full-length protein. The ratio of cleaved to uncleaved
Myc–K18 is proportional to the extent of apoptosis in the
transfected cells and therefore indicates the extent to
which the co-expressed gene protects against anoikis.
The assay was validated with the known anti-apoptotic
genes, bcl-2 and crmA, and with several neutral genes ([2]
and data not shown).
To test the hypothesis that death receptor signaling
through death domains is involved in anoikis, we tested
the effects of the death-domain inhibitors SODD and
FADD-dn in our transient assay. SODD is a recently
cloned 60 kDa protein that lacks death domains but
specifically binds to and inhibits the death domains of
tumor necrosis factor receptor type 1 (TNFR1) and
death receptor 3 (DR3) but not those of FAS or FADD
[3]. It is thought to prevent spontaneous clustering of
receptor death domains and inappropriate receptor sig-
naling. SODD is identical to a member of the BAG
family of hsp70/hsc70-binding proteins (BAG-4 [4]; J.
Reed, personal communication; reviewed in [5]). It thus
contains a carboxy-terminal BAG domain of ~70 amino
acids, which is responsible for its interaction with hsp70
and hsc 70. It is unlikely that the BAG domain of SODD
is required for its interaction with death receptors,
because the partial SODD cDNA obtained by yeast two-
hybrid screening for proteins that interact with death
receptors lacked this domain [3], and other BAG pro-
teins, such as BAG-1, do not interact with death recep-
tors (J. Reed, personal communication). 
We found that the expression of full-length SODD, but
not SODD with the BAG domain (amino acids 398–458)
deleted (SODD∆C), protected MDCK cells efficiently
from anoikis, as measured by caspase cleavage of
Myc–K18 in the transient assay (Figure 1b). These
results suggested that death domains, including or
related to those of TNFR1 or DR3, might play a role in
anoikis, and that the recruitment of hsp70 or hsc70 by
SODD is required for the prevention of anoikis induced
by this mechanism.
We then tested the effects of the death-domain inhibitor
FADD-dn (amino acids 80–205 of full-length FADD),
which contains the death domain but lacks the death
effector domain of FADD and inhibits apoptosis induced
by most death ligands (reviewed in [6]). FADD-dn also
inhibited anoikis potently in this assay (Figure 1b), con-
firming the importance of death-receptor-related death
domains in anoikis.
A hallmark of death receptor signaling is activation of
caspase 8, which in turn activates effector caspases (for
example, caspase 3; reviewed in [7]), as well as stimulat-
ing the release of mitochondrial cytochrome c by cleav-
ing the bcl-2-interacting protein BID [8,9]. We therefore
assayed for caspase-8 activation and BID cleavage fol-
lowing detachment of MDCK cells from matrix. To
ensure the specific detection of caspase 8, we assayed for
generation of the activated p18 subunit by western blot-
ting. Caspase 8 was activated in a time-dependent
fashion following suspension of MDCK cells, and BID
was cleaved with similar kinetics (Figure 2). Both co-
appeared kinetically with the fluorogenic cleavage
product of Ac-DEVD-AFC, which is primarily a sub-
strate of caspases 3 and 7.
One interpretation of these results is that epithelial cells
utilize death-receptor-related signaling interactions to
undergo anoikis. This interpretation is supported by two
findings. First, the death-domain inhibitors used in this
study, FADD-dn and SODD, have so far been shown
only to interact with the death receptors and TRADD,
which is consistent with the low overall homology of
various death domains [10]. SODD is, in fact, specific
for the receptors TNFR1 and DR3. Second, caspase 8,
which we have shown to be rapidly activated after cell
detachment, is initially auto-activated by ‘induced prox-
imity’, which is caused by clustering of death receptors,
FADD and caspase 8 [6,11]. An alternative interpreta-
tion, however, is that unidentified FADD- and SODD-
interacting proteins that contain death domains, but
which are unrelated to the death receptors, are involved
in anoikis and also cause caspase-8 activation. This
hypothesis cannot be ruled out at present. Receptor
activation could occur by de novo expression of death
ligands, as is the case for FAS ligand in PC12 cells
deprived of nerve growth factor [12]. But this is unlikely,
given that anoikis in MDCK cells is independent of
protein synthesis [13]; however, maturation of ligand
precursors, such as tumor necrosis factor α (TNFα), is a
possible control point in this connection. Death recep-
tors can signal independently of ligand if a threshold
concentration is achieved in one cellular location,
because of death receptor self-association [14]. In fact,
one proposed mechanism for p53-induced apoptosis is
enhanced cell-surface trafficking of FAS [15]. It is plau-
sible that cytoskeletal alterations, which accompany
cell–matrix detachment, could release death receptors
from a sequestered state, leading to death-domain-
induced apoptotic signaling.
1048 Current Biology Vol 9 No 18
Figure 1
Death-domain inhibitors confer resistance to anoikis. (a) Schematic
representation of the transient anoikis assay (described in detail in [2]).
MDCK cells were electroporated with the vector depicted above. On
the left, cells are transfected with vector encoding the Myc–K18
reporter gene only; on the right, cells are transfected with a vector
encoding both the Myc–K18 gene and a gene (X) to be tested for
anoikis effects. Transcription of gene X is driven by the CMV promoter;
transcription of Myc–K18 is driven by the SV40 promoter. After 36 h,
cells were suspended for 0,1 or 2 h, lysed and then analyzed for
caspase-mediated cleavage of the Myc–K18 marker protein by
western blotting. Results were quantitated by phosphorimaging. 
(b) FADD-dn and SODD, but not SODD∆C, protect MDCK cells from
anoikis. The cDNA encoding FADD-dn, full-length SODD or SODD∆C
was subcloned into the vector depicted in (a) and transfected into
MDCK cells. The MDCK cells were then suspended for the times
indicated and assayed for inhibition of Myc–K18 cleavage. The ratio of
cleaved to uncleaved Myc–K18 is shown.
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Figure 2
Caspase 8 is activated and BID is cleaved during anoikis. MDCK cells
were suspended for the indicated times, lysed and analyzed by western
blotting using anti-caspase-8 antibody (p20; Oncogene Research) or
anti-BID antiserum (J. Reed, unpublished). For comparison, the kinetics
of caspase 3/7 activity was assayed fluorimetrically [16] with Ac-DEVD-
AFC (Alexis Biochemicals) as substrate (lower panel).
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